Aicuris Anti Infective Cures competitive analysis

Explore Aicuris Anti Infective Cures's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 17, 2021N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)-Phenyl]-Acetamide Free Base Hemihydrate, Methods Of Manufacture And Uses Thereof1

Latest PTAB cases involving Aicuris Anti Infective Cures

Discover the latest PTAB cases involving Aicuris Anti Infective Cures, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Aicuris Anti Infective Cures with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AICURIS ANTI INFECTIVE CURES - 1 - -
INNOVATIVE MOLECULES GMBH11 - -